GL OB
AL &
RO UT
IN E
TE ST
S FI
BR IN
OL YS
IS TH
RO M
BO PH
IL IA
RE SE
AR CH
PR IM
AR Y
HE M
OS TA
SI S
CA LI
BR AT
OR S
& CO
NT RO
LS IN
DE X
M ON
IT OR
IN G
AN TI
CO AG
UL AN
T AU
XI LI
AR Y
RE AG
EN TS
BL EE
DI NG
DI
SO RD
ER S
121 120
A
Activated Partial Clotting Time (aPTT)..................................p.12, 13, 42 Activated Protein C Chromogenic substrate ..................... p.92 Human enzyme ........................................ p.89 Activators (Protac®/Streptokinase) ................... p.91 Activator Diluent Buffers for
chromogenic assay ................ p.104, 115 Adenosine-5 -diphosphate (ADP).................................................................... p.20 Aggregometry ............................................. p.17 Alpha 2 anti-plasmin (chromogenic assay) .................................................................. p.72 Anti-IIa activity Chromogenic assay ...p.38, 58-60, 100 Clotting method ...................................... p.60 Anti-VIII Elisa kit ............................................................ p.26 Anti-Xa activity Chromogenic assay .......... p.57-59, 100 Annexin V Elisa kit ................................................... p.46, 97 Anti-Annexin V auto antibodies ............................................. p.44, 96 Anti-β2GP1 autoantibodies Elisa kit ............................................................ p.43 Anti-cardiolipin/ Anti-Phospholipid antibodies (ACA/APA) ........................... p.43 Anti-Protein S autoantibodies ................................. p.44, 96 Anti-Protein Z autoantibodies .........................p.45, 96, 97 Antithrombin III Buffers ......................................... p.104, 115 Chromogenic assay ...........................p.37 Latex Immuno-assay .........................p.38 Human protein .....................................p.89 Apixaban Calibrators & Controls
................. p.57, 64, 66, 67, 82, 84, 85 Argatroban Calibrators & Controls .....................................p.60, 65, 67, 83, 85 Arachidonic Acid ..................................p.20 Arixtra® Calibrators & Controls ................. p.57-59, 64, 66, 82, 84, 100
B β2GP1 Elisa kit ................................................... p.46, 97 Bentonite ......................................... p.105, 116 Bivalirudin Calibrators & Controls .............................................. p.60, 65, 67, 83, 85
C Calcium Chloride .................................. p.111 Calibrators ..................................................... p.77 Collagen ........................................................... p.20 Collagen Binding Assay (CBA) .......................................... p.21, 28 Control............................................................... p.77 C-Reactive Protein (CRP) Elisa kit ................................................... p.47, 98
D Dabigatran Calibrators & Controls
............................................ p.60, 65, 67, 83, 85 D-Dimer Elisa kit ................................................... p.46, 97 Deficient Plasmas .............................. p.22, 25-33, 39, 41, 93-95 Dilution buffers .......................... p.105, 116 Direct Thrombin Inhibitors (DTI) ................................................................p.55, 56, 60
E Edoxaban Calibrators & Controls .............................................. p.57, 65, 67, 83, 85 Epinephrine .................................................. p.20
F Factor II Deficient plasma ............................ p.25, 32 Factor V Deficient plasma ............................ p.25, 32 Elisa kit ...........................................p.25, 32, 95 Factor V-Leiden Clotting method ...................................... p.41 Factor VII ............................................... p.25, 29 Chromogenic assay .............................. p.30 Deficient plasma ..................................... p.30 Elisa kit ................................................... p.30, 94 Factor VIIa Chromogenic assay ..................... p.49, 99 Clotting method ...................................... p.49
Factor VII-X Clotting method ...................................... p.30 Factor VIII:C .................................................. p.25 Chromogenic assay .............................. p.26 Deficient plasma ..................................... p.26 Factor IX .......................................................... p.25 Chromogenic assay .............................. p.27 Deficient plasma ..................................... p.27 Elisa kit ................................................... p.27, 93 Factor IXa Chromogenic assay ..................... p.49, 99 Factor X Chromogenic assay ..................... p.31, 94 Deficient plasma ..................................... p.31 Elisa kit ................................................... p.31, 94 Factor Xa Bovine enzyme ......................................... p.91 Chromogenic substrate ..................... p.92 Factor XI ........................................................... p.25 Deficient plasma ..................................... p.29 Factor XIa Chromogenic assay ..................... p.48, 99 Factor XII.......................................................... p.25 Deficient plasma ..................................... p.29 Factor XIII ........................................................ p.25 Deficient plasma ............................ p.33, 95 Chromogenic assay .............................. p.33 Factor XIIIa Elisa kit ................................................... p.33, 95 Fibrino Peptide A (FPA) Buffer and solutions for Elisa
................................................................ p.105, 116 Elisa kit ................................................... p.47, 98 Fibrinogen Elisa kit ................................................... p.14, 93 Latex immuno-assay ........................... p.14 Von Clauss Method................................ p.13
H
Heparin Chromogenic assay
........................................................... p.56-59, 100 Heparin dependent antibodies Elisa kit ................................................... p.60, 61 Hirudin Recombinant Hirudin ......................... p.90
I
Imidazole buffer .................................... p.111
K Kallikrein Chromogenic substrate ..................... p.92
L Low Molecular Weight Heparin (LMWH) ........p.55-59, 64, 66, 84, 88, 100 Lupus Anticoagulant ............................ p.42 Clotting method ............................. p.42, 43 Elisa kit ............................................................ p.43 Lyophilized platelets ............................ p.21
M Microparticles coagulant activity ..................................................... p.47, 98
N Non titrated human plasmas Chromogenic assay .................. p.43, 117
O Orgaran® Calibrator & Control ......................................p.57, 59, 65, 67, 83, 85
P Phosphate-NaCl buffers .......................................................p.102, 111, 112 Plasminogen Activator Inhibitor-1 (PAI-1) Elisa kit (Activity & Antigen) .............................................................p.72, 73, 101 Platelet aggregation ............................. p.20 Plasmin Chromogenic substrate ..................... p.92 Plasminogen Chromogenic assay .............................. p.72 Human protein ......................................... p.89 Platelet Factor 4 (PF4) Elisa kit ................................................... p.22, 93 Human protein ......................................... p.89 Prekallikrein Human protein ......................................... p.90 Protac® .............................................................. p.91 Protein C Chromogenic assay .............................. p.39 Clotting method ...................................... p.38 Deficient plasma ............................ p.39, 95 Elisa kit ............................................................ p.39 Human protein ......................................... p.89
Protein S Clotting method ...................................... p.40 Deficient plasma ............................ p.41, 95 Elisa kit ............................................................ p.40 Latex Immuno-assay ........................... p.40 Protein Z Elisa kit ................................................... p.41, 96 Prothrombin Buffer and solutions ............. p.104, 115 Deficient plasma ..................................... p.32 Human protein ......................................... p.90 Prothrombin Time (PT) Clotting method ...................................... p.12
R Ristocetin ........................................................ p.21 Rivaroxaban Calibrators & Controls ............................................... p.55-57, 64, 66, 84
S Substrates ...............................p.92, 105, 106
T Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Elisa kit ................................................ p.73, 101 Thrombin Bovine enzyme ......................................... p.91 Chromogenic substrate ..................... p.92 Human enzyme ........................................ p.90 Thrombin Time (T.T.) Clotting method ...................................... p.14 Tissue Factor Elisa kits ................................................ p.48, 98 Tissue Plasminogen Activator (tPA) Elisa kits (Antigen & Activity) ..................................................................... p.74, 101 tPA and broad spectrum Chromogenic Substrate .................... p.92 Tetra-Methyl Benidine (TMB) .......................................................p.105, 106, 117 Tris buffers ...................................... p.103, 113
U Unfractionated Heparin (UFH) Calibrators and Controls ......................... p. 55-59, 64, 66, 82, 84, 100 Urokinase Chromogenic substrate ..................... p.92
V von Willebrand Factor (vWF) ........ p.34 Deficient plasma ......................................................p. 22, 28, 93, 94 Elisa kit ................................................... p.21, 28 Latex immuno-assay .................. p.21, 28
W Wash solution ............................ p.105, 116